SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Covetrus, Inc. (CVET) .
本页证实的标准:
- VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。
SharesGrow 综合评分： 28/100 其中 0/7 项标准通过。
SharesGrow 7-Criteria Score
~
健康
50/100
Debt-to-Equity & liquidity
→ Health
估值概览 — CVET
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.63
EV/EBITDA0.0
每股数据
EPS (TTM)$-0.63
每股账面价值$0.00
每股营收$33.39
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2015 |
$0.54 |
$2.98B |
$60.32M |
2% |
| 2016 |
$0.63 |
$3.35B |
$70.3M |
2.1% |
| 2017 |
$0.58 |
$3.58B |
$64.35M |
1.8% |
| 2018 |
$0.91 |
$3.78B |
$100.86M |
2.7% |
| 2019 |
$-9.52 |
$3.98B |
$-1.02B |
-25.6% |
| 2020 |
$-0.16 |
$4.34B |
$-19M |
-0.4% |
| 2021 |
$-0.63 |
$4.58B |
$-86M |
-1.9% |
